SeaStar Medical Holding Corporation (NASDAQ:ICU) is a commercial-stage healthcare company. On August 12, 2026, SeaStar Medical is scheduled to report its second-quarter financial results after the market closes. As highlighted by GlobeNewswire, the company will also host an earnings call to discuss its performance and business progress with investors.
Wall Street analysts expect an earnings per share (EPS) of -$0.97 for the quarter. This estimate aligns with SeaStar Medical's recent performance, as SeaStar Medical has a negative Price-to-Earnings (P/E) ratio of -0.90 over the last year. A negative P/E ratio indicates that the company has not been profitable.
For the upcoming report, revenue is estimated to be $486.50 thousand. SeaStar Medical's current Price-to-Sales (P/S) ratio is 7.33. This metric shows that investors are willing to pay $7.33 for every dollar of SeaStar Medical's annual sales, which can suggest expectations of future sales growth.
The company's financial health shows a mix of factors. Its Enterprise Value-to-Sales ratio is 1.05, while its Enterprise Value-to-Operating Cash Flow ratio is -0.11. This negative cash flow figure, along with an earnings yield of -8.19%, reinforces SeaStar Medical's current lack of profitability from its core operations.
Despite its negative earnings, SeaStar Medical maintains a strong financial position in other areas. The company has a low Debt-to-Equity ratio of 0.05, showing it relies very little on debt. Furthermore, its current ratio of 2.73 suggests it has enough assets to cover its short-term debts comfortably, indicating strong liquidity.
